Bayer HealthCare and Johnson & Johnson are facing a new products liability claim from an Ohio woman alleging dangerous side effects from Xarelto.

The Ohio woman has filed the Xarelto bleeding lawsuit after allegedly experiencing dangerous side effects from Xarelto and claims the manufacturing companies failed to warn against them.

Plaintiff Katherine M. began using Xarelto on July 19, 2015, to prevent blood clot injuries and to encourage a healthier lifestyle. According to the Xarelto lawsuit, Katherine experienced metrorrhagia, or abnormal bleeding from the uterus, and required surgery on Sept. 2, 2015.

Katherine was also diagnosed with anemia allegedly due to the dangerous side effects from Xarelto, and has had to contend with the condition. During all times relevant, Katherine followed all prescription instructions and physicians advice during her Xarelto prescription.

Even with this diligence, Katherine still allegedly experienced Xarelto internal bleeding injuries and claims that she had no way of knowing the possibilities. The dangerous side effects from Xarelto she allegedly experienced were not mentioned on the drug’s warning label and no disclosure was provided from the manufacturers.

Overview of Dangerous Side Effects of Xarelto

Xarelto was approved by the FDA in 2011, which was only a year after Pradaxa was approved. After Pradaxa was successfully released into the market, Johnson & Johnson and Bayer HealthCare agreed to jointly release Xarelto.

Ever since its release, Xarelto has become one of the most popular anticoagulants in the United States. Pradaxa was the first new generation anticoagulant to be released since warfarin entered the market in the 1950s.

Xarelto and other new generation anticoagulants quickly gained popularity over warfarin, because the newer blood thinners required less patient monitoring.

Xarelto and other anticoagulants are often prescribed to treat atrial fibrillation and to prevent stroke, which works by inhibiting the body’s clotting mechanism. However this also prevents the body from recovering from internal bleeding injuries, which often results in patients becoming hospitalized.

While Xarelto and other new generation anticoagulants are more convenient, most lack an approved reversal agent in the case of internal bleeding. In patients who are prescribed warfarin, doctors implement vitamin K to stop any internal bleeding injuries.

The alleged dangerous side effects of Xarelto were well known to Bayer HealthCare and Johnson & Johnson, due to Boehringer Ingelheim coming under intense legal strain from Pradaxa internal bleeding allegations.

Katherine opted to file legal action against Johnson & Johnson and Bayer HealthCare after discovering the pharmaceutical giants may have known about the potentially dangerous side effects from Xarelto. Katherine states that she never would have opted for the medication if she had known the potentially dangerous side effects of Xarelto.

Her Xarelto lawsuit will join MDL No. 2592, where it will stand alongside other claims alleging similar dangerous side effects from Xarelto. Patients who suspect they have experienced dangerous side effects from Xarelto may be able to file legal action and should contact a lawyer.

This Xarelto Lawsuit is Case No. 2:17-cv-05952-EEF-MBN, in the U.S. District Court for the Eastern District of Louisiana.